MANKIND PHARMA
|
MANKIND PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹2,333 Cr | ₹2,525 Cr | ₹2,399 Cr | ₹1,671 Cr | ₹1,975 Cr |
| Adjustment | ₹1,277 Cr | ₹602 Cr | ₹212 Cr | ₹298 Cr | ₹31 Cr |
| Changes In working Capital | ₹105 Cr | ₹-146 Cr | ₹-18 Cr | ₹167 Cr | ₹-586 Cr |
| Cash Flow after changes in Working Capital | ₹3,714 Cr | ₹2,980 Cr | ₹2,594 Cr | ₹2,136 Cr | ₹1,419 Cr |
| Cash Flow from Operating Activities | ₹3,121 Cr | ₹2,413 Cr | ₹2,152 Cr | ₹1,813 Cr | ₹920 Cr |
| Cash Flow from Investing Activities | ₹-196 Cr | ₹-12,683 Cr | ₹-2,082 Cr | ₹-1,054 Cr | ₹-1,369 Cr |
| Cash Flow from Financing Activities | ₹-2,953 Cr | ₹10,233 Cr | ₹5.27 Cr | ₹-740 Cr | ₹605 Cr |
| Net Cash Inflow / Outflow | ₹-28 Cr | ₹-37 Cr | ₹76 Cr | ₹19 Cr | ₹155 Cr |
| Opening Cash & Cash Equivalents | ₹404 Cr | ₹382 Cr | ₹305 Cr | ₹283 Cr | ₹127 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | ₹-9.40 Cr | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | ₹67 Cr | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹16 Cr | ₹1.31 Cr | ₹1.17 Cr | ₹2.32 Cr | ₹0.48 Cr |
| Closing Cash & Cash Equivalent | ₹392 Cr | ₹404 Cr | ₹382 Cr | ₹305 Cr | ₹283 Cr |
Compare Cashflow Statement of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹102,236.1 Cr | 1.9% | 3.5% | -7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1.9% |
3.5% |
-7% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses